NIH
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.
AmplifiDx Nabs $954K in RADx Funding for POC Test Instrument Development
The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
RADx Awards $8M to Maternal Health Challenge Winners
The winning devices include home-based, point-of-care, and wearable technologies to improve postpartum health outcomes.
Endometriosis is associated with debilitating pain and increased risk of cancer and autoimmune diseases, yet diagnosis remains out of reach for many patients.